With an array of effective FDA-approved medications now available for addressing substance use disorders, it is important to understand their use and effectiveness. The purpose of this Summit is to set the stage for exploring the role of MAT as a tool for recovery. Participants will learn about the neurobiology of substance use disorders, how medication-assisted treatment affects the brain and thus the behavÂ¬ior of clients or patients who have substance use disorders, and how the use of naloxone is being used to reverse the effects of opioid overdose. A panel of persons utilizing medications to support their recovery from substance use disorders will be interviewed. State personnel will provide an update on Nebraska grant activities relating to NE's Prescription Drug Monitoring Program (PDMP), medication-assisted treatment (MAT), and pain management guidelines. The Summit will close with a panel discussion about Nebraskaâ€™s next steps in expanding the use of MAT.
This training is for physicians, nurse practitioners, and physician assistants in Nebraska. The ASAM Treatment of Opioid Use Disorder Course provides the highest quality, evidence- based practices when using medications to treat opioid use disorders. The case-based learning format will show participants how to apply this new knowledge. You will learn:
How to apply for a waiver to prescribe buprenorphine to patients with opioid use disorders
Identify and assess patients who are appropriate for treatment with medications
Specific knowledge concerning the use of medications to manage treatment of patients with opioid use disorders
Discuss the psychiatric and medical co-morbidities associated with opioid addiction
This 2-part training involves 4-hour self-paced online learning followed by a 4-hour live training on August 19, 2017 in Omaha, NE.